Log In
Print this Print this

TLR7 agonist

  Manage Alerts
Collapse Summary General Information
Company Idera Pharmaceuticals Inc.
DescriptionStabilized immune modulatory RNA that agonizes toll-like receptor 7 (TLR7)
Molecular Target Toll-like receptor 7 (TLR7)
Mechanism of ActionToll-like receptor 7 (TLR7) agonist
Therapeutic ModalityAdjuvant
Latest Stage of DevelopmentDiscovery
Standard IndicationAdjuvant
Indication DetailsVaccine adjuvant to treat and prevent cancer, infectious diseases and Alzheimer's disease (AD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today